食品伙伴網(wǎng)訊  據(jù)歐盟食品安全局（EFSA）消息，2020年5月6日，歐盟食品安全局發(fā)布了關于噻苯唑（thiabendazole）農(nóng)藥風險評估的磋商結果。

 

　　應歐盟委員會要求，歐盟食品安全局就活性物質(zhì)噻苯唑的風險評估方面提供了科學援助。本報告總結了報告成員國西班牙組織的磋商結果，并介紹了歐盟食品安全局對收到的個人意見的科學觀點和結論。部分原文報道如下：

 

　　The European Food Safety Authority （EFSA） was asked by the European Commission to provide scientific assistance with respect to the risk assessment for an active substance in light of confirmatory data requested following approval in accordance with Article 6（1） of Directive 91/414/EEC and Article 6（f） of Regulation （EC）No 1107/2009. In this context EFSA's scientific views on the specific points raised during the commenting phase conducted with Member States, the applicant and EFSA on the confirmatory data and their use in the risk assessment for thiabendazole are presented. The current report summarises the outcome of the consultation process organised by the rapporteur Member State,Spain, and presents EFSA's scientific viewsand conclusions on the individual comments received.

 

　　本文由食品伙伴網(wǎng)食品資訊中心編輯，供網(wǎng)友參考，歡迎轉載，轉載請注明出處！有任何疑問，請聯(lián)系news@foodmate.net。